Navigation Links
Dr. Oz, Host Of The Dr. Oz Show, and Harry Zhabilov Of Immunotech Laboratories Discuss Immunotherapy Treatments For Cancer, HIV/AIDS

HUNTINGTON BEACH, Calif., Feb. 6, 2013 /PRNewswire/ -- Recently was able to ask Dr. Mehmet Oz , host of the Dr. Oz show and Harry Zhabilov, President of Immunotech Laboratories (PINKSHEETS:IMMB) about Immunotherapy Treatments and how they are used to treat patients suffering with Cancer, and HIV/AIDS Virus.

Dr. Oz demonstrates an amazing wealth of knowledge in Immunotherapy.  The Doctor is not only charismatic, but also articulates his incredible knowledge about the treatment thoroughly.  Dr. Otis Brawley from the American Cancer Society also added some unique advancement comments about Immunotherapy Treatments.

Please view the video featuring Harry Zhabilov, Dr. Oz, and Dr. Otis Brawley at the following YouTube link.

Review video testimonials of now symptom free Cancer and HIV patients treated with Immunotech's IPF Technology at

About Immunotech Laboratories
Immunotech Laboratories is a drug development company committed to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases suck as HIV, Cancer, Hepatitis and Aids. Immunotech is committed to creating drugs for the better health of mankind.

About Undiscovered Companies
Undiscovered Companies is a video news provider of public and private companies looking for new marketing ideas and product exposure.  Subscribe at for free.

Safe Harbor Statement: This release may include the use of forward-looking statements intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by phrases such its management "believes," "expects," "anticipates," "foresees," "forecasts," "estimates" or other words or phrases of similar import. Similarly, statements herein that describe the Company's business strategy, outlook, objectives, plans, intentions or goals also are forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.

Disclosure: is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit our website, for complete risks and disclosures.

Immunotech Laboratories

Undiscovered Companies

SOURCE Immunotech Laboratories, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Immunotech Laboratories (IMMB) Patented "IPF" Technology A Serious Contender In The Race For HIV & Cancer Cures
2. Immunotech Laboratories Announces LOI With International Bio-Tech Partner For USA Clinical Trials Funding Of Patented HIV Medicines
3. Nelson Laboratories to Host Free Educational Device Testing Classes at 2013 MD&M West Show
4. Charleston Laboratories, Inc. Begins Enrollment for CL-108 Phase 3 Clinical Trial
5. Charleston Laboratories, Inc. beginnt mit klinischer Phase 3-Studie für CL-108
6. Heraeus Named "Supplier of the Year" by National Association of Dental Laboratories
7. New Jensen Dental White Paper Reveals How Dental Laboratories Can Increase Productivity, Profitability with a Multi-Function Pressing Furnace
8. AAIPharma Announces Promotion Of Dean Shirazi To EVP Of Analytical Laboratories
9. IDEXX Laboratories Announces Entry Into Consent Agreement with FTC Bureau of Competition Staff
10. Abuse Deterrent Medicines Developer Pisgah Laboratories, Inc. Wins Top 5 Technologies Award from CLAAD
11. Abuse-Deterrent Medication Developer, Pisgah Laboratories, Achieves Top 5 Technologies Ranking
Post Your Comments:
(Date:6/23/2016)... , June 23, 2016 Any dentist who has ... of the current process. Many of them do not even ... technical difficulties and high laboratory costs involved. And those who ... it at such a high cost that the majority of ... Dr. Parsa Zadeh , founder of Dental Evolutions ...
(Date:6/23/2016)... Research and Markets has announced the ... 2016 - Forecast to 2022" report to their offering. ... up to date financial data derived from varied research sources ... with potential impact on the market during the next five ... comprises of sub markets, regional and country level analysis. The ...
(Date:6/23/2016)... , June 23, 2016 , ... Thursday, July 7, 2016 , , , , LOCATION: , ... , , , , EXPERT PANELISTS:  , , , Frost ... Industry Analyst, Christi Bird; Senior Industry Analyst, Divyaa Ravishankar and Unmesh ... The global pharmaceutical industry is witnessing an exceptional era. Several ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX users can easily ... of Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn pictures ... . Simply select a ProHand generator and drag it above media or text in ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... Conventional wisdom ... of success. In terms of the latter, setting the bar too high can result ... more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... and Scientific Sessions in Dallas that it will receive two significant new grants ... grants came as PHA marked its 25th anniversary by recognizing patients, medical professionals ...
(Date:6/24/2016)... ... 2016 , ... People across the U.S. are sharpening their pencils and honing ... contest in which patients and their families pay tribute to a genetic counselor by ... Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. , In ...
(Date:6/24/2016)... ... June 24, 2016 , ... National recruitment firm ... sciences executive with extensive sequencing and genomics experience, as Vice President of North American ... Hill will be responsible for leading the sales team in the commercialization of the ...
Breaking Medicine News(10 mins):